<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01073007</url>
  </required_header>
  <id_info>
    <org_study_id>STARS07</org_study_id>
    <secondary_id>EC07/90195</secondary_id>
    <nct_id>NCT01073007</nct_id>
  </id_info>
  <brief_title>Stroke Treatment With Acute Reperfusion and Simvastatin</brief_title>
  <official_title>Multicentric, Randomized, Double-blind Clinical Trial to Evaluate the Efficacy of Simvastatin in the Acute Phase of Ischemic Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari Vall d'Hebron Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitari Vall d'Hebron Research Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether simvastatin treatment started within the
      first 12 hours from stroke onset improves neurological and functional outcomes, evaluated at
      seventh day/discharge or at the third month.

      Also, to demonstrate that simvastatin is safe and not associated with higher rates of
      hemorrhagic transformation in patients who receive thrombolysis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary outcome of this study is to determine whether simvastatin treatment started within the first 12 hours from stroke onset improves neurological and functional outcomes, evaluated at seventh day/discharge or at the third month.</measure>
    <time_frame>Seventh day (or discharge) and third month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The secondary outcome of this study is to demonstrate that simvastatin is safe and not associated with higher rates of hemorrhagic transformation in patients who receive thrombolysis.</measure>
    <time_frame>24 to 78 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">104</enrollment>
  <condition>Stroke, Acute</condition>
  <arm_group>
    <arm_group_label>Simvastatin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Simvastatin 40 mg daily for 3 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Simvastatin</intervention_name>
    <description>Simvastatin 40 mgrs daily for three months.</description>
    <arm_group_label>Simvastatin</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients older than 18 years acute ischemic stroke (less than 12 hours from stroke
             onset).

          -  Stroke involving MCA-ACA-PCA.

          -  NIHSS score 4 to 22.

          -  Previous modified Rankin Scale score of 1 or 0.

          -  Patient or proxy informed consent.

          -  Patients not taking statins for the past six months.

        Exclusion Criteria:

          -  Pregnancy or breastfeeding.

          -  Clinical or radiological evidence on admission of intracranial hemorrhage, hemorrhagic
             infarction or tumor.

          -  Seizures at the time of inclusion.

          -  Complete or substantial recovery prior to randomization.

          -  Patients with ipsilateral neurological deficit that may mask the evaluation of the
             current event.

          -  Liver disease (AST or ALT more than twice upper normality limit).

          -  Cardiogenic shock or relevant cardiac failure.

          -  Patients with more than five times upper normality limit of CPK.

          -  Myocardial infarction or any other thromboembolic event within the previous 30 days.

          -  Active infection by the time of inclusion.

          -  Documented hypersensibility to statins.

          -  Drug abuse.

          -  Expected short life-expectancy related to other systemic diseases.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joan Montaner, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Vall Hebron Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marc Ribó, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Vall Hebron. Stroke Unit</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carmen Jimenez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Son Dureta. Stroke Unit.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francesc Muñoz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de Mollet.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Canovas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Consorci Sanitari Parc Taulí Sabadell.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jurek Krupinski, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Mutua de Terrassa. Neurology Department</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maite Martinez-Zabaleta, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de Donostia. Neurology Department</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francisco Javier De la Torre Laviana, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Virgen del Rocio. Stroke Unit.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marimar Freijo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de Basurto</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tomás Segura, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario de Albacete</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Juan Arenillas, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario de Valladolid</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jose Manuel Flores, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de Ciudad Real</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francisco Alonso, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital General de Vic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jaime Masjuán Vallejo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Ramón y Cajal. Stroke unit.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francisco Rubio Borrego, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario de Bellvitge. Stroke Unit.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Javier Tejada García, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de León</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aida Lago Martín, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario la Fe. Stroke Unit.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yolanda Bravo Anguiano, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital General Yagüe</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xavier Ustrell Roig, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Joan XXIII</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francisco Purroy García, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Arnau de Vilanova de Lleida</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Raquel Delgado Mederos, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Santa Creu i Sant Pau</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital General de Vic</name>
      <address>
        <city>Vic</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Albacete</name>
      <address>
        <city>Albacete</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Bellvitge</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Basurto</name>
      <address>
        <city>Bilbao</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General Yagüe</name>
      <address>
        <city>Burgos</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Ciudad Real</name>
      <address>
        <city>Ciudad Real</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Donostia</name>
      <address>
        <city>Donostia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de León</name>
      <address>
        <city>León</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Arnau de Vilanova de Lleida</name>
      <address>
        <city>Lleida</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Ramón y Cajal</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Mollet</name>
      <address>
        <city>Mollet del Vallès</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Son Dureta</name>
      <address>
        <city>Palma de Mallorca</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Consorci Sanitari Parc Tauli</name>
      <address>
        <city>Sabadell</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen del Rocío</name>
      <address>
        <city>Sevilla</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Joan XXIII</name>
      <address>
        <city>Tarragona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Mutua de Terrassa</name>
      <address>
        <city>Terrassa</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Fe</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Valladolid</name>
      <address>
        <city>Valladolid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 18, 2010</study_first_submitted>
  <study_first_submitted_qc>February 19, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 22, 2010</study_first_posted>
  <last_update_submitted>December 20, 2016</last_update_submitted>
  <last_update_submitted_qc>December 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 21, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute Stroke</keyword>
  <keyword>tissue plasminogen activator</keyword>
  <keyword>simvastatin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Simvastatin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

